H-1B Wage Lookup

Data through FY2026 Q3 (Jun 30, 2026)

RAPT Therapeutics, Inc. (Formerly FLX Bio, Inc.)

Company profile for RAPT Therapeutics, Inc. (Formerly FLX Bio, Inc.) covers 3 filings across the reporting window. FY2025 certified median offer: $174,000.

FY2025 certified median
$174,000
Total filings
3
FY2025 25th–75th percentile
$136,000–$212,000
Top job title
Director, Biologics Process Development
Certified offers by fiscal year
Fiscal yearFilingsMedian25th percentile75th percentile
FY20241$223,450$223,450$223,450
FY20252$174,000$136,000$212,000

FY2026 is partial (*). Its filing totals are not comparable to a full fiscal year.

Median offer by fiscal year

Certified median offer, RAPT Therapeutics, Inc. (Formerly FLX Bio, Inc.)FY2024 $223,450; FY2025 $174,000$0$80,000$160,000$240,000FY2024$223,450FY2025$174,000Certified median offer, RAPT Therapeutics, Inc. (Formerly FLX Bio, Inc.)FY2024 $223,450; FY2025 $174,000$0$80k$160k$240kFY2024$223,450FY2025$174,000
Certified H-1B LCAs, $15k–$2M, DOL OFLC

Top titles

  1. Director, Biologics Process Development1 filings
  2. Director, Regulatory Operations1 filings
  3. Research Associate II, DMPK1 filings

Top cities

  1. Lathrop1 filings
  2. South San Francisco1 filings
  3. North Chelmsford1 filings

Employer and title details